ImmunoPrecise Antibodies
Hospitals & Physicians Clinics · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4464 Markham St 3204, Victoria, British ...Website
www.ipatherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About ImmunoPrecise Antibodies
ImmunoPrecise Antibodies (IPA), operating under the brand MindWalk, is a publicly traded (NASDAQ: IPA) AI-driven biotherapeutic research and technology company headquartered in Austin, Texas. The company specializes in full-continuum therapeutic antibody discovery and development, integrating industry-leading antibody discovery services with advanced artificial intelligence technologies, including its proprietary LensAI platform. IPA leverages systems biology, multi-omics modeling, and in silico machine intelligence to support pharmaceutical and biotechnology partners across the drug discovery lifecycle from target analysis and immunization through developability profiling, optimization, engineering, and preclinical services. With over 35 years of experience and more than 3,000 completed monoclonal programs, IPA serves therapeutic, diagnostic, and companion antibody markets, offering platforms such as B cell Select and phage display. The company positions itself as a hub of biotherapeuRead more
Popular SearchesImmunoPrecise Antibodies LtdSIC Code 80,804NAICS Code 62,621Show more
ImmunoPrecise Antibodies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ImmunoPrecise Antibodies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on ImmunoPrecise Antibodies recently announced quarterly report
Funding: Get notified immidiatlly once ImmunoPrecise Antibodies has new funding data
Check if ImmunoPrecise Antibodies has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when ImmunoPrecise Antibodies launches new products
Click to see if ImmunoPrecise Antibodies had a recent Job posting/layoffs
ImmunoPrecise Antibodies, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if ImmunoPrecise Antibodies is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at ImmunoPrecise Antibodies
Recommended Actions
Reach out to Masked Content who joined ImmunoPrecise Antibodies as Masked Content
Find 3 more new buyers
Compare Similar Companies to ImmunoPrecise Antibodies
Compare insights from companies similar to ImmunoPrecise Antibodies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ImmunoPrecise Antibodies is experiencing very low activity levels compared to other companies in the Hospitals & Physicians Clinics sector.
What does this means?
ImmunoPrecise Antibodies is drawing exceptional interest within the Hospitals & Physicians Clinics industry, suggesting notable developments or strong market momentum, learn more about ImmunoPrecise Antibodies.
ImmunoPrecise Antibodies Tech Stack
A closer look at the technologies used by ImmunoPrecise Antibodies
See more technologies
Top Hospitals & Physicians Clinics Companies
Top companies in Australia by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding ImmunoPrecise Antibodies
Sign Up For FreeTo access detailed company insights
ImmunoPrecise Antibodies (IPA), operating under the brand MindWalk, is a publicly traded (NASDAQ: IPA) AI-driven biotherapeutic research and technology company headquartered in Austin, Texas. The company specializes in full-continuum therapeutic antibody discovery and development, integrating industry-leading antibody discovery services with advanc... Read More
